Provention Bio, Inc. (PRVB) Social Stream
PROVENTION BIO INC (PRVB) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering PRVB.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-09 | 5 | $25 | $16 | $19.875 | $8.92 | 122.81% |
| 2022-05-20 | 5 | $25 | $12 | $18.3 | $8.92 | 105.16% |
| 2022-08-04 | 5 | $22.5 | $12 | $16.9 | $8.92 | 89.46% |
| 2022-08-06 | 5 | $21 | $10 | $16.2 | $8.92 | 81.61% |
| 2022-08-24 | 5 | $21 | $10 | $15.8 | $8.92 | 77.13% |
| 2022-10-06 | 6 | $21 | $10 | $14.833 | $8.92 | 66.29% |
| 2022-10-07 | 6 | $21 | $10 | $15.666 | $8.92 | 75.63% |
| 2022-11-04 | 6 | $24 | $10 | $16.166 | $8.92 | 81.23% |
| 2022-11-06 | 6 | $24 | $10 | $16.666 | $8.92 | 86.84% |
| 2022-11-08 | 6 | $24 | $12 | $17 | $8.92 | 90.58% |
| 2022-11-17 | 6 | $24 | $12 | $17.666 | $8.92 | 98.05% |
| 2022-11-21 | 6 | $24 | $16 | $18.333 | $8.92 | 105.53% |
| 2022-12-19 | 6 | $30 | $16 | $20.5 | $8.92 | 129.82% |
The Trend in the Analyst Price Target
Over the past 24 months, PRVB's average price target has gone down $8.5.
Over the past 46 weeks, PRVB's average upside potential has been 213.39%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-03-09 | 5 | 25.0 | 14 | 19.75 | 6.64 | 197.44% |
| 2022-05-09 | 5 | 25.0 | 12 | 18.30 | 3.85 | 375.32% |
| 2022-08-04 | 5 | 22.5 | 12 | 16.90 | 4.28 | 294.86% |
| 2022-08-06 | 5 | 21.0 | 10 | 16.20 | 4.41 | 267.35% |
| 2022-11-21 | 6 | 30.0 | 16 | 20.50 | 7.77 | 163.84% |
PRVB Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 6 | 0 | 0 | 0 | 0 | 6 |
The Trend in the Broker Recommendations
PRVB's average broker recommendation rating improved by 0.33 over the prior 43 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- PRVB has a greater average analyst price target than 349.08% of all US stocks.
- PROVENTION BIO INC's upside potential (average analyst target price relative to current price) is higher than 1203.73% of all US stocks.
- In terms of how PROVENTION BIO INC fares relative to all US stocks, note that its number of analysts covering the stock is greater than 467.26% of that group.
- PROVENTION BIO INC's variance in analysts' estimates is lower than -1008.39% of all US stocks.
In terms of price targets and recommendations offered by analysts, the stocks in the Pharmaceutical Products industry with the ratings most similar to PROVENTION BIO INC are CRNX, TCDA, and MGTA.
View All Top Stocks by Price Target
What is the outlook for PRVB? Use POWR Ratings for clearer insight into price direction.